Kidney Health Toolkit
Improving the Quality of Kidney Care
Driving Health Care Quality: A Call to Action
More than 10% of U.S. adults have diabetes, which puts them at increased risk of developing kidney disease. In fact, diabetes is a leading cause of chronic kidney disease (CKD): About 1 in 3 people with diabetes also have CKD. Although CKD results in progressive loss of kidney function, it is often asymptomatic until the late stages of the disease—90% of adults with CKD are unaware they have it.
Ongoing monitoring of kidney health is crucial for diabetes care. Early diagnosis and appropriate treatment can prevent or delay progression of CKD. Clinical practice guidelines recommend screening patients with diabetes for kidney disease every year using a blood test (estimated Glomerular Filtration Rate or eGFR) to assess kidney function and a urine test (urine Albumin-to-Creatinine Ration or uACR) to assess kidney damage. Evidence shows that contrary to clinical guidance, fewer than half of people with diabetes receive an annual kidney assessment that includes both recommended tests. People with undiagnosed CKD, especially those with diabetes, miss out on life-changing health care.
The Kidney Health Toolkit helps improve the quality of kidney care by equipping organizations with tools that guide and facilitate strategies to promote kidney health in their populations.
Learn more about how providers, health plans and health systems can promote kidney health.
Access the Kidney Health Toolkit
This document is owned and copyrighted by the National Committee for Quality Assurance (NCQA). It was produced by NCQA with financial support from Bayer Healthcare Pharmaceutical, Inc. (Bayer). NCQA does not endorse any Bayer products or services. © 2021 NCQA. All rights reserved.